BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares reached a new 52-week high on Wednesday . The stock traded as high as $1.36 and last traded at $1.27, with a volume of 74859 shares traded. The stock had previously closed at $1.34.
BioRestorative Therapies Price Performance
The firm has a market capitalization of $2.08 billion, a P/E ratio of -1.25 and a beta of 102.36. The company’s 50-day simple moving average is $1.36 and its two-hundred day simple moving average is $1.67.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- P/E Ratio Calculation: How to Assess Stocks
- High-Yield Texas Instruments Could Hit New Highs Soon
- What Are Dividend Achievers? An Introduction
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
